On Wednesday 6th November 2024, investors and market participants can expect the release of Cardlytics (NASDAQ: CDLX) third quarter financial results. This crucial announcement will be made after market close.
As per the predictions of financial analysts on Wall Street, the concern is set to report an estimated per share $0.24 loss for the third quarter. Additionally, the company is projected to unveil a revenue of $57.79 million for the period.
The company's yearly performance has been analyzed by Wall Street analysts, who have projected a total revenue of $263.55 million. Additionally, they are expecting the company to achieve a per share loss of $0.64 for the fiscal year 2024.
In comparison to the same quarter of the prior year, the company's financial statement showcased a per share of loss of $0.01. This was credited to the company's total revenue, which reached an impressive $79.01 million in that particular timeframe.
Additionally, The company will host a conference call with investors and analysts on 6th November 2024 at 05:00 PM eastern time to review the Q3 2024 financial results.
Throughout Friday's trading, Cardlytics (CDLX) shares fluctuated between $4.09 and $4.46, with a trading volume of 767.60 thousand shares. The stock ended the regular trading session at $4.18, indicating fall of 3.02 percent.
